AstraZeneca voluntary recalls sterile products manufactured at its facility

29 Feb 2012 Evaluate

AstraZeneca Pharma India is undertaking a recall of sterile products manufactured at its facility in Bangalore, following an internal audit conducted by the company. This recall is a purely voluntary action on the part of the company taken as a measure of extra and abundant caution although there is no patient safety issue reported relating to sterility.

The company firmly believes that the health and safety of the end users of these products is of paramount and overriding importance. With this the company is ensuring that international quality standards are maintained globally on a consistent basis.

Further, a temporary interruption of supplies of affected products is expected. The company is also exploring all options to resume quality supplies of its sterile products at the earliest opportunity.

AstraZeneca Pharma India is engaged in the business of manufacturing and marketing pharmaceutical products in healthcare segments namely gastrointestinal, cardiovascular, cancer, respiratory, neurosciences and infection.

Astrazeneca Pharma I Share Price

8092.00 -8.10 (-0.10%)
03-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.10
Dr. Reddys Lab 1151.25
Cipla 1495.15
Lupin 2094.50
Zydus Lifesciences 901.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...